synthesi
novel
pyrazolylnucleosid
describ
structur
regioisom
elucid
use
extens
nmr
studi
pyrazolylnucleosid
screen
anticanc
activ
sixti
human
tumor
cell
line
compound
show
good
activ
cancer
cell
line
particular
show
signific
inhibit
lung
cancer
cell
line
gi
breast
cancer
cell
line
hs
gi
molecul
conform
use
reach
particular
conform
rotam
studi
affin
biomacromolecul
natur
ligand
well
molecular
recognit
oligonucleotid
chain
rnadna
similar
studi
antisens
antigen
oligonucleotid
on
potenti
select
inhibitor
gene
express
use
antitumor
antivir
agent
also
influenc
develop
field
nucleic
acidbas
drug
among
nucleosid
analogu
signific
biolog
activ
dideoxynucleosidebas
compound
dideoxycytidin
ddc
dideoxyinosin
ddi
azidothymidin
azt
effect
therapeut
agent
treatment
aid
ribavirin
virazol
antivir
drug
figur
similarli
dideoxynucleosid
deoxythymidin
stavudin
azddu
dideoxyuridin
gone
clinic
studi
differ
nucleosid
isol
natur
oxazinomycin
pyrazofurin
showdomycin
formycin
formycin
b
shown
antibiot
properti
also
found
exhibit
anticanc
andor
antivir
activ
figur
exampl
new
develop
chemistri
biolog
compound
analog
motiv
us
work
area
led
us
investig
interest
chemic
biolog
properti
novel
nucleosidebas
compound
chemistri
nucleosid
extens
studi
sever
analog
found
exhibit
potenti
fungicid
antitumor
antivir
agent
modif
heterocycl
base
sugar
moieti
led
activ
safer
nucleosid
analogu
found
applic
agent
effect
human
immunodefici
viru
hiv
caus
agent
acquir
immun
defici
syndrom
aid
also
viral
infect
caus
herp
simplex
viru
hsv
type
varicella
zoster
viru
vzv
hepat
c
viru
hcv
human
cytomegaloviru
hcmv
epsteinbarr
viru
ebv
nucleosid
nucleotid
modif
result
increas
interest
regioand
stereoselect
synthesi
nucleosid
moreov
modifi
nucleosid
nucleotid
restrict
biomacromolecul
natur
ligand
well
molecular
recognit
oligonucleotid
chain
rnadna
similar
studi
antisens
antigen
oligonucleotid
on
potenti
select
inhibitor
gene
express
use
antitumor
antivir
agent
also
influenc
develop
field
nucleic
acidbas
drug
among
nucleosid
analogu
signific
biolog
activ
dideoxynucleosidebas
compound
ddc
ddi
azt
effect
therapeut
agent
treatment
aid
ribavirin
virazol
antivir
drug
figur
similarli
dideoxynucleosid
stavudin
azddu
gone
clinic
studi
differ
nucleosid
isol
natur
oxazinomycin
pyrazofurin
showdomycin
formycin
formycin
b
shown
antibiot
properti
also
found
exhibit
anticanc
andor
antivir
activ
figur
exampl
new
develop
chemistri
biolog
compound
analog
motiv
us
work
area
led
us
investig
interest
chemic
biolog
properti
novel
nucleosidebas
compound
despit
develop
nucleosid
chemistri
clinic
use
nucleosid
drawback
due
sideeffect
primari
acquir
drug
resist
therefor
search
design
new
effect
nucleosidebas
analogu
continu
motiv
studi
field
effort
toward
goal
led
synthesi
twenti
novel
pyrazolylnucleosid
new
structur
potent
antivir
antitumor
behavior
regard
two
regioisom
pyrazol
deriv
produc
character
use
spectroscop
techniqu
h
nmr
c
nmr
noesi
hmbc
ir
mass
spectroscopi
compound
evalu
nation
cancer
institut
nci
panel
human
tumor
cell
line
anticanc
activ
antivir
activ
repres
virus
approach
synthesi
target
compound
achiev
two
step
start
alreadi
report
wellknown
chlorid
scheme
treatment
pyrazol
sodium
hydrid
acetonitril
subsequ
addit
chlorosugar
gave
two
regioisom
modifi
pyrazolyl
nucleosid
coupl
nitrogen
pyrazol
deriv
coupl
chlorosugar
nitrogen
pyrazol
deriv
yield
product
detoluoyl
despit
develop
nucleosid
chemistri
clinic
use
nucleosid
drawback
due
sideeffect
primari
acquir
drug
resist
therefor
search
design
new
effect
nucleosidebas
analogu
continu
motiv
studi
field
effort
toward
goal
led
synthesi
twenti
novel
pyrazolylnucleosid
new
structur
potent
antivir
antitumor
behavior
regard
two
regioisom
pyrazol
deriv
produc
character
use
spectroscop
techniqu
h
nmr
c
nmr
noesi
hmbc
ir
mass
spectroscopi
compound
evalu
nation
cancer
institut
nci
panel
human
tumor
cell
line
anticanc
activ
antivir
activ
repres
virus
approach
synthesi
target
compound
achiev
two
step
start
alreadi
report
wellknown
chlorid
scheme
treatment
pyrazol
sodium
hydrid
acetonitril
subsequ
addit
chlorosugar
gave
two
regioisom
modifi
pyrazolyl
nucleosid
coupl
nitrogen
pyrazol
deriv
coupl
chlorosugar
nitrogen
pyrazol
deriv
yield
product
detoluoyl
use
sodium
methoxid
methanol
result
format
correspond
modifi
nucleosid
yield
respect
use
sodium
methoxid
methanol
result
format
correspond
modifi
nucleosid
yield
respect
scheme
synthesi
pyrazolylnucleosid
analogu
pyrazol
substitut
either
two
n
ring
atom
alkyl
produc
two
regioisom
strongli
basic
condit
anion
gener
produc
two
reson
form
react
chlorosugar
glycosid
step
lead
mixtur
two
regioisomer
pyrazolyl
nucleosid
ie
scheme
mechanist
explan
regioisomer
alkyl
pyrazol
deriv
iupac
number
scheme
retain
easi
comparison
structur
identif
isomer
disubstitut
pyrazolyl
nucleosid
base
h
nmr
spectral
data
see
supplementari
materi
report
literatur
observ
anomer
proton
isomer
pyrazolyl
nucleosid
exhibit
differ
proton
chemic
shift
anomer
proton
adjac
pyrazol
compound
would
appear
downfield
compar
anomer
proton
adjac
pyrazol
compound
addit
use
h
nmr
chemic
shift
extens
noe
nmr
experi
employ
confirm
structur
isomer
pyrazolyl
nucleosid
use
h
c
nmr
studi
confirm
posit
assign
isomer
pyrazolyl
nucleosid
synthes
present
work
tabl
anomer
proton
analogu
gener
appear
ppm
upfield
compar
correspond
proton
h
nmr
spectra
correspond
seri
isom
agreement
observ
pyrazol
nucleosid
pyrazol
substitut
either
two
n
ring
atom
alkyl
produc
two
regioisom
strongli
basic
condit
anion
gener
produc
two
reson
form
react
chlorosugar
glycosid
step
lead
mixtur
two
regioisomer
pyrazolyl
nucleosid
ie
scheme
pyrazol
substitut
either
two
n
ring
atom
alkyl
produc
two
regioisom
strongli
basic
condit
anion
gener
produc
two
reson
form
react
chlorosugar
glycosid
step
lead
mixtur
two
regioisomer
pyrazolyl
nucleosid
ie
scheme
mechanist
explan
regioisomer
alkyl
pyrazol
deriv
iupac
number
scheme
retain
easi
comparison
structur
identif
isomer
disubstitut
pyrazolyl
nucleosid
base
h
nmr
spectral
data
see
supplementari
materi
report
literatur
observ
anomer
proton
isomer
pyrazolyl
nucleosid
exhibit
differ
proton
chemic
shift
anomer
proton
adjac
pyrazol
compound
would
appear
downfield
compar
anomer
proton
adjac
pyrazol
compound
addit
use
h
nmr
chemic
shift
extens
noe
nmr
experi
employ
confirm
structur
isomer
pyrazolyl
nucleosid
use
h
c
nmr
studi
confirm
posit
assign
isomer
pyrazolyl
nucleosid
synthes
present
work
tabl
anomer
proton
analogu
gener
appear
ppm
upfield
compar
correspond
proton
h
nmr
spectra
correspond
seri
isom
agreement
observ
pyrazol
nucleosid
scheme
mechanist
explan
regioisomer
alkyl
pyrazol
deriv
iupac
number
scheme
retain
easi
comparison
structur
identif
isomer
disubstitut
pyrazolyl
nucleosid
base
h
nmr
spectral
data
see
supplementari
materi
report
literatur
observ
anomer
proton
isomer
pyrazolyl
nucleosid
exhibit
differ
proton
chemic
shift
anomer
proton
adjac
pyrazol
compound
would
appear
downfield
compar
anomer
proton
adjac
pyrazol
compound
addit
use
h
nmr
chemic
shift
extens
noe
nmr
experi
employ
confirm
structur
isomer
pyrazolyl
nucleosid
use
h
c
nmr
studi
confirm
posit
assign
isomer
pyrazolyl
nucleosid
synthes
present
work
tabl
anomer
proton
analogu
gener
appear
ppm
upfield
compar
correspond
proton
h
nmr
spectra
correspond
seri
isom
agreement
observ
pyrazol
nucleosid
found
effect
less
pronounc
seri
nucleosid
compar
seri
nucleosid
differ
rang
ppm
c
chemic
shift
ch
cn
bear
pyrazol
carbon
atom
help
distinguish
posit
isom
seri
nucleosid
carbon
signal
ppm
downfield
rel
correspond
signal
seri
nucleosid
case
aryl
bear
pyrazol
carbon
seri
ppm
upfield
rel
correspond
carbon
seri
howev
case
versu
differ
small
revers
make
aryl
bear
pyrazol
carbon
less
reliabl
use
posit
assign
tabl
chemic
shift
valu
anomer
proton
h
nmr
spectra
chemic
shift
valu
arand
ch
cn
bear
carbon
pyrazol
ring
c
nmr
spectra
isomer
pyrazolyl
nucleosid
cdcl
bruker
avanc
spectromet
arbear
c
shift
tabl
chemic
shift
coupl
constant
hnmr
compound
aceton
pleas
refer
structur
tabl
skeleton
number
tabl
measur
aceton
bruker
avanc
instrument
may
therefor
differ
tabl
measur
cdcl
bruker
avanc
instrument
due
spatial
interact
differ
proton
explicitli
shown
tabl
proton
exhibit
multipl
shown
spectra
record
aceton
bruker
avanc
instrument
record
cdcl
cd
cn
dmsod
given
experiment
section
correspond
proton
appear
broad
singlet
ill
resolv
multiplet
spectra
record
bruker
avanc
instrument
tabl
measur
aceton
bruker
avanc
instrument
may
therefor
differ
tabl
measur
cdcl
bruker
avanc
instrument
order
confirm
posit
assign
perform
nmr
experi
noesi
hmbc
two
pair
compound
ie
one
pair
consist
ditoluoyl
protect
nucleosid
anoth
pair
consist
deprotect
nucleosid
tabl
result
hmbc
experi
reli
fact
anomer
proton
may
see
aryl
bear
pyrazol
carbon
noesi
result
would
explain
spatial
proxim
anomer
proton
either
proton
ch
cn
group
ortho
proton
aryl
group
result
verifi
posit
properti
pyrazol
ring
four
compound
summar
tabl
isom
seri
nucleosid
gener
higher
r
f
valu
tlc
correspond
isom
seri
nucleosid
observ
isom
seri
rel
seri
nucleosid
tabl
result
noesi
hmbc
spectra
pair
blue
red
arrow
indic
noesi
hmbc
cross
peak
respect
presenc
cross
peak
indic
x
contribut
posit
verif
underlin
x
see
tabl
posit
relev
proton
carbon
nmr
spectra
compound
anticanc
toxic
compound
evalu
use
nation
cancer
human
cancer
cell
line
compound
sugar
attach
pyrazol
ring
found
inact
cell
line
irrespect
substitu
aromat
ring
seri
compound
substitu
respect
aromat
ring
also
inact
howev
compound
substitu
aromat
ring
respect
show
inhibit
multipl
anticanc
cell
line
cytostat
paramet
toxic
paramet
valu
select
cell
line
given
tabl
compound
show
inhibit
cell
line
activ
renal
cancer
cell
line
breast
cancer
cell
line
hs
case
activ
compound
show
moder
inhibit
cell
line
show
signific
inhibit
lung
cancer
cell
line
breast
cancer
cell
line
hs
importantli
compound
show
toxic
even
highest
concentr
test
indic
high
valu
pyrazolyl
nucleosid
also
examin
antivir
activ
number
virus
simplex
viru
type
type
thymidin
kinasedefici
tk
strain
vaccinia
viru
viru
sindbi
viru
coxsacki
viru
punta
toro
viru
vesicular
stomat
viru
vsv
coxsacki
viru
respiratori
syncyti
viru
rsv
felin
corona
viru
felin
herp
viru
howev
none
compound
show
signific
activ
virus
blue
red
arrow
indic
noesi
hmbc
cross
peak
respect
anticanc
toxic
compound
evalu
use
nation
cancer
institut
human
cancer
cell
line
compound
sugar
attach
pyrazol
ring
found
inact
cell
line
irrespect
substitu
aromat
ring
seri
compound
substitu
respect
aromat
ring
also
inact
howev
compound
substitu
aromat
ring
respect
show
inhibit
multipl
anticanc
cell
line
gi
cytostat
paramet
lc
toxic
paramet
valu
select
cell
line
given
tabl
compound
show
inhibit
cell
line
activ
renal
cancer
cell
line
breast
cancer
cell
line
hs
gi
case
activ
compound
show
moder
inhibit
cell
line
show
signific
inhibit
lung
cancer
cell
line
gi
breast
cancer
cell
line
hs
gi
importantli
compound
show
toxic
even
highest
concentr
test
indic
high
lc
valu
pyrazolyl
nucleosid
also
examin
antivir
activ
number
virus
simplex
viru
type
type
thymidin
kinasedefici
tk
strain
vaccinia
viru
viru
sindbi
viru
coxsacki
viru
punta
toro
viru
vesicular
stomat
viru
vsv
coxsacki
viru
respiratori
syncyti
viru
rsv
felin
corona
viru
felin
herp
viru
howev
none
compound
show
signific
activ
virus
reaction
conduct
atmospher
nitrogen
anhydr
solvent
column
chromatographi
carri
use
silica
gel
mesh
melt
point
determin
concentr
h
acid
bath
uncorrect
analyt
tlc
perform
precoat
merck
silica
gel
plate
spot
detect
either
use
uv
light
char
alcohol
sulfur
acid
ir
spectra
record
perkinelm
ftir
spectrophotomet
waltham
usa
optic
rotat
measur
bellinghamstanley
ad
polarimet
concentr
express
gml
hnmr
cnmr
spectra
record
bruker
avanc
spectromet
billerica
usa
mhz
respect
cdcl
dmsod
cd
cn
measur
perform
aceton
bruker
avanc
spectromet
billerica
usa
chemic
shift
rel
intern
tm
assign
base
cosi
noesi
hmbc
use
bruker
microprogram
includ
lowpass
jfilter
suppress
onebond
correl
hsqc
jre
spectra
chemic
shift
valu
report
ppm
rel
tm
use
intern
standard
coupl
constant
j
measur
hz
esihrm
spectra
compound
record
jeol
highresolut
mass
spectromet
tokyo
japan
posit
ion
mode
use
matrix
hed
bishydroxyethylsulfid
dope
sodium
acet
acetonitril
use
distil
freshli
ignit
potassium
carbon
solut
mmol
acetonitril
ml
ad
stir
mixtur
sodium
hydrid
mmol
acetonitril
ml
nitrogen
atmospher
c
continu
stir
min
reaction
mixtur
cool
c
mmol
ad
content
stir
c
h
progress
reaction
monitor
use
silica
gel
tlc
complet
reaction
mixtur
pour
icecold
water
extract
ethyl
acet
ml
combin
organ
layer
wash
water
ml
dri
anhydr
sodium
sulfat
solvent
remov
reduc
pressur
residu
thu
obtain
column
chromatograph
silica
gel
ethyl
acet
petroleum
ether
eluent
afford
pyrazolyl
nucleosid
yield
respect
suspend
dri
methanol
ml
mixtur
naom
meoh
ml
vv
ad
result
solut
content
stir
room
temperatur
h
progress
reaction
monitor
use
silica
gel
tlc
complet
nh
cl
ad
reaction
mixtur
adjust
ph
onethird
solvent
remov
reduc
pressur
reaction
mixtur
pour
water
extract
ethyl
acet
ml
organ
layer
dri
anhydr
sodium
sulfat
solvent
remov
reduc
pressur
residu
thu
obtain
subject
column
chromatographi
silica
gel
methanol
chloroform
eluent
afford
detail
methodolog
describ
http
dtpncinihgovbranchesbtbivclsphtml
briefli
panel
organ
nine
subpanel
repres
divers
histolog
leukemia
melanoma
cancer
lung
colon
kidney
ovari
breast
prostat
central
nervou
system
cell
grown
supplement
medium
h
five
dose
studi
test
compound
dissolv
dmso
incub
cell
five
concentr
dilut
highest
other
assay
termin
addit
cold
trichloroacet
acid
cell
fix
stain
sulforhodamin
b
bound
stain
solubil
absorb
read
autom
plate
reader
cytostat
paramet
determin
growth
inhibit
gi
tumor
cell
calcul
time
zero
control
growth
absorb
five
concentr
level
cytotox
paramet
lethal
concentr
lc
concentr
drug
result
reduct
measur
protein
end
drug
treatment
compar
begin
indic
net
loss
cell
follow
treatment
calcul
averag
two
independ
experi
success
achiev
synthesi
twenti
novel
pyrazolyl
nucleosid
character
detail
use
variou
nmr
spectroscop
techniqu
h
nmr
c
nmr
noesi
hmbc
etc
pyrazolyl
nucleosid
screen
anticanc
activ
human
tumor
cell
line
identifi
one
compound
show
good
activ
cancer
cell
line
show
signific
inhibit
lung
cancer
cell
line
gi
breast
cancer
cell
line
hs
gi
studi
demonstr
potenti
newli
synthes
pyrazolylnucleosid
pursu
supplementari
materi
follow
avail
onlin
http
scan
copi
nmr
ir
spectra
select
compound
appropri
given
supplementari
inform
author
contribut
yy
kk
ds
synthes
compound
vk
svm
compil
activ
aj
interpret
nmr
data
draft
manuscript
jw
cl
akp
vsp
plan
design
whole
studi
final
manuscript
fund
pleas
add
research
receiv
extern
fund
see
acknowledg
section
detail
